Senior Principal Scientist
Genentech, Inc., United States
Sebastian Guelman is a Senior Principal Scientist in the BioAnalytical Sciences Department at Genentech. He currently leads the development of bioanalytical strategies to support a number of cancer immunotherapy programs in Genentech’s pipeline, including new modalities such as the Individualized Neoantigen-specific Immunotherapy (iNeST) and neoantigen-directed T-cell therapies. Prior to joining Genentech, Sebastian worked at Iconic Therapeutics, developing pre-clinical pharmacokinetic, immunogenicity and biomarker assays to support an antibody-drug conjugate program. Prior to that role, Sebastian worked for two other companies, developing immunoassays in different platforms for clinical diagnostics. Sebastian received his PhD degree in Biochemistry and Molecular Biology from the Pennsylvania State University and was a post-doctoral fellow in the Department of Pathology at Genentech.
Disclosure information not submitted.
Tuesday, April 25, 2023
9:30 AM – 11:00 AM ET
Wednesday, April 26, 2023
10:00 AM – 11:00 AM ET